Related Experiment Video
Updated: Nov 28, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality
Atsushi Sakuraba1, Haider Haider1, Toshiro Sato2,3
1Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago Medicine, Chicago, IL 60637, USA.
Insights
Human leukocyte antigen (HLA) class I, specifically HLA-C*05, is linked to COVID-19 mortality. Genetic variations in innate immunity may explain differing country death rates, warranting further study.
Area of Science:
- Immunogenetics
- Viral Pathogenesis
- Epidemiology
Background:
- Coronavirus disease 2019 (COVID-19) exhibits significant global mortality disparities.
- Human leukocyte antigen (HLA) class I is crucial for viral infection susceptibility.
- Investigating the role of HLA class I in COVID-19 mortality differences is essential.
Purpose of the Study:
- To examine the association between human leukocyte antigen (HLA) class I allele frequencies and COVID-19 mortality rates across countries.
- To explore the correlation between HLA-C*05, its natural killer (NK) cell receptor KIR2DS4fl, and differential COVID-19 mortality.
Main Methods:
- Collected HLA allele frequency data for 74 countries from public databases.
- Utilized linear and multivariable regression to assess associations between HLA allele frequencies and COVID-19 mortality.
- Analyzed the interaction of HLA-C*05 with KIR2DS4fl and its relation to historical pandemic mortality patterns.
Main Results:
- HLA-A*01, -B*07, -B*08, -B*44, and -C*05 showed initial associations with COVID-19 mortality risk.
- HLA-C*05 remained the only statistically significant factor after multivariable regression (p=0.000027).
- A 1% increase in HLA-C*05 frequency correlated with 44 additional deaths per million, linked to NK cell hyperactivation.
Conclusions:
- The allele frequency of HLA-C*05 and its interaction with KIR2DS4fl strongly correlate with COVID-19 mortality.
- Host genetic variations in innate immunity likely contribute to observed international differences in COVID-19 mortality.
- Further research with patient samples is recommended to validate these findings.
Background:
coronavirus disease 2019 (COVID-19) causes severe illness including cytokine storms, but mortality among countries differs largely. In the present study, we investigated the association between human leukocyte antigen (HLA) class I, which plays a major role in susceptibility to viral infections, and the mortality of COVID-19.
Methods:
data of allele frequencies of HLA-A, -B and -C and COVID-19 mortality were obtained for 74 countries from the Allele Frequency Net Database and worldometer.info. Association between allele frequency of each HLA and mortality was assessed by linear regression followed by multivariable regression. Subsequently, association of HLA-C*05 to its receptor KIR2DS4fl, expressed on natural killer (NK) cells, and differential mortality to historic pandemics were analyzed.
Results:
HLA-A*01, -B*07, -B*08, -B*44 and -C*05 were significantly associated with the risk of deaths (adjusted p = 0.040, 0.00081, 0.047, 0.0022, 0.00032, respectively), but only HLA-C*05 remained statistically significant (p = 0.000027) after multivariable regression. A 1% increase in the allele frequency of HLA-C*05 was associated with an increase of 44 deaths/million. Countries with different mortality could be categorized by the distribution of HLA-C*05 and its receptor KIR2DS4fl, which in combination cause NK cell-induced hyperactive immune response. Countries with similar ethnic and/or geographic background responded in a similar pattern to each pandemic.
Conclusions:
we demonstrated that allele frequency of HLA-C*05 and the distribution pattern with its receptor KIR2DS4fl strongly correlated with COVID-19 mortality. Host genetic variance of innate immunity may contribute to the difference in mortality among various countries and further investigation using patient samples is warranted.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11:22Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Causality in Epidemiology
Correlation
Two variables, for example, a and b, are said to be positively correlated if both variables move in the same direction. In other words, a positive correlation exists between two variables, a and b, if:
Test for Homogeneity
Bias in Epidemiological Studies
Hardy-Weinberg Principle